Asper Biotech

Asper Biotech Overview

Founded 1999
Status Acquired/​Merged
Employees 25
Latest Deal Type M&A

Asper Biotech General Information


Provider of genetic testing services focusing on diagnostics for rare and common hereditary diseases. The company's testing portfolio's include research on ophthalmics, reprogenetics, oncogenetics, cardiogenetics, neurogenetics, otogenetics, hematology, and dysmorphology, enabling university hospitals, private clinics, commercial laboratories and research organizations access to genetic testing and research.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Asper Biogen
Primary Office
  • Oru 3
  • Tartu
  • Estonia
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Asper Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 01-Jul-2017 000 Completed Generating Revenue
1. Early Stage VC 000 000 Completed Generating Revenue

Asper Biotech Executive Team (1)

Name Title Board Seat Contact Info
Alo Merilo Chief Executive Officer

Asper Biotech Former Investors (1)

To view Asper Biotech‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Estonian Biocentre Corporation Majority 000 0000 000000 0

Ready to get started?

Request a free trial